在庫拠点

New Jersey, USA
Czech Republic, EU
Mumbai, India

* 在庫状況によります

Documentation

MSDSをダウンロード

サンプルCOAをダウンロード

内容: HPLC、MASS/LC-MS、1H NMR、FT-IR、含量、構造解析レポート（SER）、および製品に応じた追加分析データ。

57762-79-5Bacitracin B1

● 在庫あり

カタログ番号:	VE0022982
CAS番号:	57762-79-5
分子式:	C65H101N17O16S
分子量:	1408.66 g/mol

見積もり依頼

RFQリストに追加

に関する追加情報 CAS 57762-79-5

親薬物

Bacitracin

IUPAC名

(R)-5-(((2S, 3S)-1-(((3S, 6R, 9S, 12R, 15S, 18R, 21S)-9-((1H-imidazol-5-yl) methyl)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-6-(carboxymethyl)-15-isopropyl-2, 5, 8, 11, 14, 17, 20-heptaoxo-1, 4, 7, 10, 13, 16, 19-heptaazacyclopentacosan-21-yl)amino)-3-methyl-1-oxopentan-2-yl)amino)-4-((S)-2-((R)-2-((1S, 2S)-1-amino-2-methylbutyl)-4, 5-dihydrothiazole-4-carboxamido)-4-methylpentanamido)-5-oxopentanoic acid

薬局方同義語

N/A

Other Synonyms

N/A

SMILES

O=C(O)CC[C@@H](NC([C@@H](NC([C@H]1N=C([C@@H](N)[C@@H](C)CC)SC1)=O)CC(C)C)=O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H]2C(N[C@H](CCCN)C(N[C@@H](C(C)C)C(N[C@H](CC3=CC=CC=C3)C(N[C@@H](CC4=CN=CN4)C(N[C@H](CC(O)=O)C(N[C@@H](CC(N)=O)C(NCCCC2)=O)=O)=O)=O)=O)=O)=O)=O)=O

InChI

InChI=1S/C65H101N17O16S/c1-9-35(7)51(68)65-80-47(31-99-65)62(96)75-42(25-33(3)4)58(92)73-41(21-22-49(84)85)57(91)82-53(36(8)10-2)64(98)74-39-19-14-15-24-70-54(88)45(28-48(67)83)77-61(95)46(29-50(86)87)78-60(94)44(27-38-30-69-32-71-38)76-59(93)43(26-37-17-12-11-13-18-37)79-63(97)52(34(5)6)81-56(90)40(20-16-23-66)72-55(39)89/h11-13, 17-18, 30, 32-36, 39-47, 51-53H, 9-10, 14-16, 19-29, 31, 66, 68H2, 1-8H3, (H2, 67, 83)(H, 69, 71)(H, 70, 88)(H, 72, 89)(H, 73, 92)(H, 74, 98)(H, 75, 96)(H, 76, 93)(H, 77, 95)(H, 78, 94)(H, 79, 97)(H, 81, 90)(H, 82, 91)(H, 84, 85)(H, 86, 87)/t35-, 36-, 39-, 40+, 41+, 42-, 43+, 44-, 45-, 46+, 47-, 51-, 52-, 53-/m0/s1

説明

The compound Bacitracin B1 is a thoroughly characterized reference standard that complies with rigorous regulatory guidelines | including those from USP | EMA | JP | and BP. It is ideal for critical applications such as analytical method development | method validation (AMV) | and quality control (QC) | especially in the production of Bacitracin. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | this product delivers the precision required for reliable results. Additionally | it includes a detailed Structure Elucidation Report (SER) | ensuring accuracy and dependability for advanced analytical purposes.